http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 23 Oct 2024 06:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/Press+Releases/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.marugh" idsrc="xmltag.org" >MARLBOROUGH, Mass.</location></span>, <span class="legendSpanClass"><chron>Oct. 23, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific Corporation</span> (NYSE: BSX) generated net sales of <money>$4.209 billion</money> during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational¹ basis and 18.2 percent on an organic² basis, all compared to the prior year period. The company reported GAAP net income attributable to <span value="NYSE:BSX" idsrc="xmltag.org" >Boston Scientific</span> common stockholders of <money>$469 million</money> or <money>$0.32</money> per share (EPS), compared to <money>$505 million</money> or <money>$0.34</money> per share a year ago, and achieved adjusted³ EPS of <money>$0.63</money> for http://www.streetinsider.com/PRNewswire/Boston+Scientific+Announces+Results+for+Third+Quarter+2024/23867269.html Wed, 23 Oct 2024 06:30:00 -0400 A.06822034 A.15618092 A.50114112 BSX O.00016491 O.06063085 O.20026344 O.37622762 SILK http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Silk+Road+Medical+Inc++++++++++++++++/23774114.html si-local-file:///var/storage/secattach/20240927/23774114.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Silk+Road+Medical+Inc++++++++++++++++/23774114.html Fri, 27 Sep 2024 16:01:00 -0400 O.06063085 SILK http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Silk+Road+Medical+Inc++++++++++++++++/23774114.html si-local-file:///var/storage/secattach/20240927/23774114.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Silk+Road+Medical+Inc++++++++++++++++/23774114.html Fri, 27 Sep 2024 16:01:00 -0400 O.06063085 SILK http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Silk+Road+Medical+Inc++++++++++++++++/23753128.html si-local-file:///var/storage/secattach/20240924/23753128.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Silk+Road+Medical+Inc++++++++++++++++/23753128.html Tue, 24 Sep 2024 06:01:00 -0400 O.06063085 SILK http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Silk+Road+Medical+Inc++++++++++++++++/23753128.html si-local-file:///var/storage/secattach/20240924/23753128.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Silk+Road+Medical+Inc++++++++++++++++/23753128.html Tue, 24 Sep 2024 06:01:00 -0400 O.06063085 SILK http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Silk+Road+Medical+Inc++++++++++++++++++Filed+by%3A+Magnetar+Financial+LLC/23740255.html si-local-file:///var/storage/secattach/20240919/23740255.html http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Silk+Road+Medical+Inc++++++++++++++++++Filed+by%3A+Magnetar+Financial+LLC/23740255.html Thu, 19 Sep 2024 08:17:00 -0400 O.06063085 SILK http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Silk+Road+Medical+Inc++++++++++++++++++Filed+by%3A+Magnetar+Financial+LLC/23740255.html si-local-file:///var/storage/secattach/20240919/23740255.html http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Silk+Road+Medical+Inc++++++++++++++++++Filed+by%3A+Magnetar+Financial+LLC/23740255.html Thu, 19 Sep 2024 08:17:00 -0400 O.06063085 SILK http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Silk+Road+Medical+Inc+++++For%3A+Sep+17++Filed+by%3A+Zurbay+Donald/23738797.html si-local-file:///var/storage/secattach/20240918/23738797.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Silk+Road+Medical+Inc+++++For%3A+Sep+17++Filed+by%3A+Zurbay+Donald/23738797.html Wed, 18 Sep 2024 21:13:00 -0400 O.06063085 SILK